Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

The FDA approved copper histidinate (Zycubo) as the first treatment for Menkes disease in pediatric patients, the agency ...

Among patients with opioid overdose, bradycardia on initial vital signs was associated with a higher likelihood of xylazine ...

The SGLT2 inhibitor empagliflozin (Jardiance) showed some potential for heart failure (HF) prevention in high-risk, ...

Thousands of New York City nurses returned to the picket lines Tuesday as their strike targeting some of the city's leading ...

The new rule does not estimate the economic value of health benefits from reducing NOx and other types of air pollution under ...

In a phase IIIb trial of adults with active psoriatic arthritis (PsA) and obesity or overweight, adding the GLP-1 drug ...

Michael David McKee, MD, 39, a vascular surgeon from Chicago, has been charged with premeditated aggravated murder in the ...

On January 7, 2026, the Trump administration released the much-anticipated Dietary Guidelines for Americans 2025-2030. The ...

Spring & Mulberry recalled a lot of its Mint Leaf Date Sweetened Chocolate Bar that was sold online and through retail ...

Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled prion disease; a 2025 study offered explanations, but some patients rejected ...

Patient characteristics associated with increased difficulty included personality disorders (relative risk [RR] 2.2, 95% CI 1 ...